Vitalipid N

Medicinal product

(Invented) name

Vitalipid N

Active substance (s)

Retinolis/Fitomenadionas/Ergokalciferolis/Visų racematų alfa tokoferolis

Strength

99 µg/15 µg/0,5 µg/0,91 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Purpose for use

suaugusiesiems

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

B05XC, Vitamins

Marketing authorisation holder

Fresenius Kabi AB, Švedija

Date of authorisation

1995-10-04

Date of renewal

2008-11-24

Documents

Stage

Perregistruotas

Controlled?

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

1 ml koncentrato yra	1 ml
Retinolis	99 µg
Fitomenadionas	15 µg
Ergokalciferolis	0,5 µg
Visų racematų alfa tokoferolis	0,91 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
2670	8243	1008243	ampulė	10 ml N10		Receptinis	LT/1/95/1343/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2008-11-24	Perregistruotas
1995-10-04	Registruotas